825 related articles for article (PubMed ID: 19530975)
1. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
2. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
[TBL] [Abstract][Full Text] [Related]
3. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
4. Physicians' treatment decisions, patient persistence, and interruptions in the continuous use of prostaglandin therapy in glaucoma.
Hahn SR; Kotak S; Tan J; Kim E
Curr Med Res Opin; 2010 Apr; 26(4):957-63. PubMed ID: 20163296
[TBL] [Abstract][Full Text] [Related]
5. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
Wilensky J; Fiscella RG; Carlson AM; Morris LS; Walt J
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S28-33. PubMed ID: 16389058
[TBL] [Abstract][Full Text] [Related]
6. Systemic antihypertensive medication and incident open-angle glaucoma.
Müskens RP; de Voogd S; Wolfs RC; Witteman JC; Hofman A; de Jong PT; Stricker BH; Jansonius NM
Ophthalmology; 2007 Dec; 114(12):2221-6. PubMed ID: 17568677
[TBL] [Abstract][Full Text] [Related]
7. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
[TBL] [Abstract][Full Text] [Related]
8. Cost comparison of prostaglandin analogues: a Canadian population-based analysis.
Iskedjian M; Walker JH; Desjardins O; Covert D; Einarson TR
J Med Econ; 2008; 11(2):299-310. PubMed ID: 19450087
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension.
Heo JH; Rascati KL; Wilson JP; Lawson KA; Richards KM; Nair R
J Manag Care Spec Pharm; 2019 Sep; 25(9):1001-1010. PubMed ID: 31456491
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
Katz LJ; Simmons ST; Craven ER
Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
12. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
Robin AL; Covert D
Ophthalmology; 2005 May; 112(5):863-8. PubMed ID: 15878067
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides.
Martínez A; Sánchez M
Curr Med Res Opin; 2007 Mar; 23(3):595-9. PubMed ID: 17355740
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
15. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
Chiselită D;
Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
[TBL] [Abstract][Full Text] [Related]
17. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema?
Chang JH; McCluskey P; Missotten T; Ferrante P; Jalaludin B; Lightman S
Br J Ophthalmol; 2008 Jul; 92(7):916-21. PubMed ID: 18460537
[TBL] [Abstract][Full Text] [Related]
18. A gap analysis approach to assess patient persistence with glaucoma medication.
Lee PP; Walt JG; Chiang TH; Guckian A; Keener J
Am J Ophthalmol; 2007 Oct; 144(4):520-4. PubMed ID: 17692273
[TBL] [Abstract][Full Text] [Related]
19. Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.
Nordmann JP; Berdeaux G
Clin Ther; 2007 Aug; 29(8):1751-60; discussion 1750. PubMed ID: 17919556
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation rates of topical glaucoma medications in a managed care population.
Shaya FT; Mullins CD; Wong W; Cho J
Am J Manag Care; 2002 Aug; 8(10 Suppl):S271-7. PubMed ID: 12188170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
